Your shopping cart is currently empty

PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC molecule that effectively suppresses EZH2 methyltransferase activity, with a half-maximal IC50 of 2.7 nM. EZH2 is a histone methyltransferase crucial to tumorigenesis and cancer progression, and PROTAC EZH2 Degrader-1 represents an important chemical tool for probing its therapeutic relevance.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $215 | 7-10 days | 7-10 days | |
| 5 mg | $645 | 7-10 days | 7-10 days | |
| 10 mg | $975 | 7-10 days | 7-10 days |
| Description | PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC molecule that effectively suppresses EZH2 methyltransferase activity, with a half-maximal IC50 of 2.7 nM. EZH2 is a histone methyltransferase crucial to tumorigenesis and cancer progression, and PROTAC EZH2 Degrader-1 represents an important chemical tool for probing its therapeutic relevance. |
| Targets&IC50 | EZH2:2.7 nM |
| In vitro | Methods: H128 cells were pretreated with PROTAC EZH2 Degrader-1 (2 nM), followed by treatment with carboplatin, etoposide, and teniposide for 72 hours. Cell viability was assessed using the CCK8 assay. Results: PROTAC EZH2 Degrader-1 significantly reduced the IC50 values of carboplatin, etoposide, and teniposide in H128-LM cells.[2] |
| In vivo | Methods: PROTAC EZH2 Degrader-1 (0.5 mg/kg, once weekly for a total of 3 doses) was administered intraperitoneally to H128-LM xenograft mice to evaluate tumor growth. Results: The combination of PROTAC EZH2 degrader-1 with carboplatin, etoposide, and teniposide significantly inhibited the growth of H128-LM tumors, demonstrating superior efficacy compared to chemotherapy drugs used alone.[2] |
| Molecular Weight | 942.15 |
| Formula | C54H67N7O8 |
| Cas No. | 2641601-67-2 |
| Smiles | O=C(NCC=1C(=O)NC(=CC1C)C)C2=CC(=CC(=C2C)N(CC)C3CCOCC3)C4=CC=C(C=C4)CN5CCN(CC5)CCCCCCCOC6=CC=CC=7C(=O)N(C(=O)C67)C8C(=O)NC(=O)CC8 |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (84.91 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.